King CR - Search Results

1

Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Bruder JT, Chen P, Semenova E, Thomas CA, Konovalova S, Ekberg G, Ettyreddy D, McVey D, Gall JG, King CR, Brough DE. Bruder JT, et al. Among authors: king cr. J Virol. 2013 Sep;87(17):9661-71. doi: 10.1128/JVI.00462-13. Epub 2013 Jul 3. J Virol. 2013. PMID: 23824800 Free PMC article.

2

Rescue and production of vaccine and therapeutic adenovirus vectors expressing inhibitory transgenes.

Gall JG, Lizonova A, EttyReddy D, McVey D, Zuber M, Kovesdi I, Aughtman B, King CR, Brough DE. Gall JG, et al. Among authors: king cr. Mol Biotechnol. 2007 Mar;35(3):263-73. doi: 10.1007/BF02686012. Mol Biotechnol. 2007. PMID: 17652790

3

Replication-defective adenovirus vectors with multiple deletions do not induce measurable vector-specific T cells in human trials.

Koup RA, Lamoreaux L, Zarkowsky D, Bailer RT, King CR, Gall JG, Brough DE, Graham BS, Roederer M. Koup RA, et al. Among authors: king cr. J Virol. 2009 Jun;83(12):6318-22. doi: 10.1128/JVI.00384-09. Epub 2009 Apr 1. J Virol. 2009. PMID: 19339347 Free PMC article.

4

Characterization of human adenovirus 35 and derivation of complex vectors.

McVey D, Zuber M, Ettyreddy D, Reiter CD, Brough DE, Nabel GJ, King CR, Gall JG. McVey D, et al. Among authors: king cr. Virol J. 2010 Oct 19;7:276. doi: 10.1186/1743-422X-7-276. Virol J. 2010. PMID: 20959004 Free PMC article.

5

Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.

Bruder JT, Semenova E, Chen P, Limbach K, Patterson NB, Stefaniak ME, Konovalova S, Thomas C, Hamilton M, King CR, Richie TL, Doolan DL. Bruder JT, et al. Among authors: king cr. PLoS One. 2012;7(4):e33920. doi: 10.1371/journal.pone.0033920. Epub 2012 Apr 5. PLoS One. 2012. PMID: 22496772 Free PMC article.

6

Repeated administration of adenovector in the eye results in efficient gene delivery.

Hamilton MM, Brough DE, McVey D, Bruder JT, King CR, Wei LL. Hamilton MM, et al. Among authors: king cr. Invest Ophthalmol Vis Sci. 2006 Jan;47(1):299-305. doi: 10.1167/iovs.05-0731. Invest Ophthalmol Vis Sci. 2006. PMID: 16384977

7

Repeat administration of proteins to the eye with a single intraocular injection of an adenovirus vector.

McVey D, Hamilton MM, Hsu C, King CR, Brough DE, Wei LL. McVey D, et al. Among authors: king cr. Mol Ther. 2008 Aug;16(8):1444-9. doi: 10.1038/mt.2008.124. Epub 2008 Jun 10. Mol Ther. 2008. PMID: 18545220 Free article.

8

Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.

Ko SY, Cheng C, Kong WP, Wang L, Kanekiyo M, Einfeld D, King CR, Gall JG, Nabel GJ. Ko SY, et al. Among authors: king cr. J Virol. 2009 Jan;83(2):748-56. doi: 10.1128/JVI.01811-08. Epub 2008 Nov 5. J Virol. 2009. PMID: 18987146 Free PMC article.

9

Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

Hamilton MM, Byrnes GA, Gall JG, Brough DE, King CR, Wei LL. Hamilton MM, et al. Among authors: king cr. Mol Vis. 2008;14:2535-46. Epub 2008 Dec 30. Mol Vis. 2008. PMID: 19122827 Free PMC article.

10

Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.

Bruder JT, Stefaniak ME, Patterson NB, Chen P, Konovalova S, Limbach K, Campo JJ, Ettyreddy D, Li S, Dubovsky F, Richie TL, King CR, Long CA, Doolan DL. Bruder JT, et al. Among authors: king cr. Vaccine. 2010 Apr 19;28(18):3201-10. doi: 10.1016/j.vaccine.2010.02.024. Epub 2010 Feb 25. Vaccine. 2010. PMID: 20188680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters